The third-generation hydroxy acid family — gluconolactone and lactobionic acid headline. Larger molecule sizes (gluconolactone 178 Da, lactobionic 358 Da) keep them on the surface, delivering exfoliation without the dermal sting of AHAs. Bonus: humectant action and antioxidant capacity (lactobionic chelates iron). Neostrata (originator), Zelens, and The Inkey List anchor the OTC category; K-beauty mid-tier (COSRX, Beauty of Joseon adjacent SKUs) drove 2024–2025's mainstream surge.
Benefits
barrier-friendly exfoliation for rosacea, eczema, and post-procedure skin
humectant — leaves skin feeling hydrated rather than stripped
antioxidant and anti-glycation activity (notably lactobionic)
Example uses
sensitive-skin exfoliating toners
post-procedure recovery serums
anti-glycation aging routines
Mechanism of action
A larger-molecule subset of the hydroxy-acid family. Gluconolactone (178 Da) is a glucono-δ-lactone — a six-carbon ring sugar acid; lactobionic acid (358 Da) is a disaccharide of galactose and gluconic acid. Both keratolytically loosen corneodesmosomes but their size restricts penetration to the upper stratum corneum, dramatically reducing dermal irritation and the sting characteristic of small AHAs. Beyond exfoliation, both function as polyhydric humectants (multiple OH groups binding water) and antioxidants — lactobionic in particular is a metal chelator with documented anti-glycation activity. The combination of exfoliation, humectancy, and barrier-friendliness is distinctive.
Clinical evidence · Moderate
Solid clinical work on PHAs in rosacea, atopic-dermatitis-adjacent skin, and post-procedure recovery (notably Edison/Green dermatology series); effect sizes on photoaging endpoints are lower than glycolic at comparable percentages.
Effective concentration range
4–10%
Formulation notes
Effective at 4–10%. Often stacked with mild lactic or low-% mandelic for graded exfoliation. Works in leave-on serums, toners, and even sensitive-skin masks. pH 3.5–4.5 is typical but PHAs tolerate slightly higher pH than AHAs without losing efficacy.
Watchouts
Slower payoff and higher cost per percent than glycolic — easy to underdose. 'PHA' marketing sometimes hides homeopathic doses.
The 'gentler exfoliation' positioning is real; the trade-off is slower and smaller payoff on photoaging endpoints — easily underdosed by brands wanting the PHA marketing without the cost. Lactobionic acid is one of the more expensive cosmetic actives by weight, which produces a recurring gap between 'contains PHA' and 'usefully dosed with PHA'.
Market positioning
Sold as the inclusive-derm-era exfoliant — Neostrata pioneered the category; Naturium, Inkey, and Allies of Skin scaled it. Real value is meaningful for rosacea, eczema-prone, post-procedure, and Fitzpatrick V–VI consumers who need exfoliation without PIH or irritation risk.